Beijing Scitop Bio-tech published an announcement showing the recent receipt of two patent certificates from the China National Intellectual Property Administration. The patents are titled “A Strain of Infant Bifidobacterium B8762 and its Application in the Preparation of Probiotics” and “Lactobacillus rhamnosus and its Application in Alleviating Autoimmune and Skin Allergy”. As of now, the market value of Scitop Bio-tech is RMB 5 billion yuan (USD $690 million), with a closing price of RMB 19.15 yuan (USD $2.66). (Source: 163.com)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE